Citius Oncology (CTOR) Enterprise Value: 67.71M

Citius Oncology, Inc. (CTOR)

0.7003 +0.03 (+4.37%) USD | NASDAQ | Oct 21, 16:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.

Date	Value
October 21, 2026	67.71M
October 20, 2026	64.61M
October 19, 2026	68.78M
October 16, 2026	74.86M
October 15, 2026	72.54M
October 14, 2026	76.52M
October 13, 2026	77.41M
October 12, 2026	79.59M
October 09, 2026	82.46M
October 08, 2026	81.96M
October 07, 2026	83.65M
October 06, 2026	83.54M
October 05, 2026	86.03M
October 02, 2026	94.12M
October 01, 2026	97.29M
September 30, 2026	100.46M
September 29, 2026	104.69M
September 28, 2026	102.58M
September 25, 2026	104.69M
September 24, 2026	104.69M
September 23, 2026	100.46M
September 22, 2026	106.81M
September 21, 2026	104.16M
September 18, 2026	114.21M
September 17, 2026	101.52M

Date	Value
September 16, 2026	94.52M
September 15, 2026	84.18M
September 14, 2026	93.06M
September 11, 2026	90.68M
September 10, 2026	89.89M
September 09, 2026	93.06M
September 08, 2026	91.91M
September 04, 2026	84.60M
September 03, 2026	77.43M
September 02, 2026	75.90M
September 01, 2026	72.97M
August 31, 2026	74.36M
August 28, 2026	75.67M
August 27, 2026	77.23M
August 26, 2026	76.89M
August 25, 2026	79.32M
August 24, 2026	72.97M
August 21, 2026	72.31M
August 20, 2026	73.93M
August 19, 2026	73.23M
August 18, 2026	68.00M
August 17, 2026	71.91M
August 14, 2026	89.87M
August 13, 2026	81.09M
August 12, 2026	79.47M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks